INVEST IN
UNDISPUTED
QUALITY.

SUPERIOR QUALITY CRAFT CANNABIS.

line.png

Avant’s brand portfolio includes BLK MKT™, Tenzo™, Cognōscente™, Treehugger™ and Flowr, which are produced from unique cultivars, and sold in B.C., Saskatchewan, Manitoba, Ontario, Quebec, Atlantic Canada and the Territories. The Company’s medical cannabis brand, GreenTec™, is distributed nationwide, directly to qualified patients through its online portal. 

Avant is a publicly traded corporation, with its primary listing on the Toronto Stock Exchange (TSX: AVNT) and secondary listings on the OTCQX (OTCQX: AVTBF) & Frankfurt Stock Exchange (FRA: 1BU0). The Company is headquartered in Kelowna, British Columbia and has operations in British Columbia, Alberta and Ontario.

TSX: AVNT.

OTCQX: AVTBF   |   FRA: 1BU0

LEADERSHIP & DIRECTORS.

We have a lean team that is focused on growing premium craft cannabis, being industry leaders, and making decisions to deliver long-term shareholder value.

 
Team-09.png

Norton Singhavon

FOUNDER, CEO & DIRECTOR

Norton has extensive experience in capital investments, acquisitions, consolidations, and start-ups in the legal cannabis sector. He has deployed over $100 million into the North American cannabis industry and has been involved in numerous public M&A cannabis transactions.

 
Team-04.png

David Lynn

CHIEF OPERATING OFFICER

David has 30 years of diverse business experience, having previously worked at Dairyland, Saputo, Sun-Rype, Earth's Own, and Molson Breweries. David holds a Bachelor of Commerce (Marketing, Honours) and MBA (Finance) from the University of British Columbia.

 

Jeremy Wright

CHIEF FINANCIAL OFFICER

Jeremy Wright is a seasoned executive with over 20 years' senior management experience, specializing in finance and strategic planning. He played a pivotal role in the growth and success of GTEC Holdings (rebranded to Avant and uplisted to the TSX in 2021), serving as the company’s founding CFO.

 
Team-06.png

Jurgen Schreiber

CHAIRMAN OF THE BOARD

Jurgen is a highly accomplished executive with extensive senior management experience in the global retail pharmacy, health and beauty sectors. He was previously President & CEO of Shoppers Drug Mart, President & CEO of Rexall Health, and CEO at Katz Group.

 
Team-08.png

Michael Blady

CO-FOUNDER & DIRECTOR

As a venture capitalist, Michael has been involved in the startup and senior management of numerous public companies. He helped oversee the acquisition, growth, and management of a diverse portfolio of cannabis centric businesses as a director and senior executive of multiple Licensed Producers.

 

Sylvia Lee

INDEPENDENT DIRECTOR

Sylvia has an extensive background in corporate and commercial law, focusing on providing general counsel to business with a particular emphasis on mergers and acquisitions, private equity, venture capital, tax, outsourcing and corporate and tax reorganizations. 

 
Avant-BOD-Duane-Lo.png

Duane Lo

INDEPENDENT DIRECTOR

Duane has extensive senior finance experience across a broad range of companies, including Entrée Resources, Luna Gold, First Quantum and Deloitte & Touche. Duane is a Chartered Accountant.

 
Team-05.png

Tyson Macdonald

INDEPENDENT DIRECTOR

Tyson brings over 20 years of C-suite expertise in investment and transactions across diverse markets and sectors. Today, Tyson remains committed to actively investing in the US Cannabis Market.

 

Derek Sanders

INDEPENDENT DIRECTOR

Derek is a partner at Spence Valuation Group, where he specializes in business valuation, mergers & acquisitions and financial litigation support. Derek has extensive experience in the valuation of privately-held companies for purchase & sales transactions, shareholder disputes, and corporate reorganizations and estate freezes.

 

IN THE NEWS.

Keep up to date with the latest Avant Brands news and updates.

INVESTOR PRESENTATION.

 

Download the latest version of our Corporate Presentation.

 

 

EXPORT
PRESENTATION.

Download the latest version of our Export Presentation.

 

 

Download the latest version of our Fact Sheet.

FACT
SHEET.

Financials.

 

MD&A


2023
Q1 Q2 Q3 Q4

2022
Q1 Q2 Q3 Q4

2021
Q1 Q2 Q3 Q4

2020
Q1 Q2 Q3 Q4

 

Consolidated Financial Statements


2023
Q1 Q2 Q3 Q4

2022
Q1 Q2 Q3 Q4

2021
Q1 Q2 Q3 Q4

2020
Q1 Q2 Q3 Q4

Notice of Online Voting and Proxy

Earnings Call



SHARE STRUCTURE.

 SHARE STRUCTURE (AS OF FEBRUARY 28, 2024)

 

278.6 Million Shares Outstanding

16.1 Million Options Outstanding

44.9 Million Warrants Outstanding

3.7 Million RSUs and DSUs Outstanding

63.4 Million Total Options, Warrants, RSUs and DSUs Outstanding

24.3 Million Insider Ownership (9%)

342.0 Million Total Shares Fully Diluted

Please refer to our Management’s Discussion and Analysis dated October 16, 2023.

 
line.png

Invest in undisputed quality